These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
466 related articles for article (PubMed ID: 23200667)
1. GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft. Fu J; Rodova M; Roy SK; Sharma J; Singh KP; Srivastava RK; Shankar S Cancer Lett; 2013 Mar; 330(1):22-32. PubMed ID: 23200667 [TBL] [Abstract][Full Text] [Related]
2. Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathway. Li SH; Fu J; Watkins DN; Srivastava RK; Shankar S Mol Cell Biochem; 2013 Jan; 373(1-2):217-27. PubMed ID: 23129257 [TBL] [Abstract][Full Text] [Related]
3. NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200. Fu J; Rodova M; Nanta R; Meeker D; Van Veldhuizen PJ; Srivastava RK; Shankar S Neuro Oncol; 2013 Jun; 15(6):691-706. PubMed ID: 23482671 [TBL] [Abstract][Full Text] [Related]
4. Sanguinarine inhibits pancreatic cancer stem cell characteristics by inducing oxidative stress and suppressing sonic hedgehog-Gli-Nanog pathway. Ma Y; Yu W; Shrivastava A; Alemi F; Lankachandra K; Srivastava RK; Shankar S Carcinogenesis; 2017 Oct; 38(10):1047-1056. PubMed ID: 28968696 [TBL] [Abstract][Full Text] [Related]
5. PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth. Sharma N; Nanta R; Sharma J; Gunewardena S; Singh KP; Shankar S; Srivastava RK Oncotarget; 2015 Oct; 6(31):32039-60. PubMed ID: 26451606 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog. Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics. Tang SN; Fu J; Nall D; Rodova M; Shankar S; Srivastava RK Int J Cancer; 2012 Jul; 131(1):30-40. PubMed ID: 21796625 [TBL] [Abstract][Full Text] [Related]
9. NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128. Nanta R; Kumar D; Meeker D; Rodova M; Van Veldhuizen PJ; Shankar S; Srivastava RK Oncogenesis; 2013 Apr; 2(4):e42. PubMed ID: 23567619 [TBL] [Abstract][Full Text] [Related]
10. GANT-61 and GDC-0449 induce apoptosis of prostate cancer stem cells through a GLI-dependent mechanism. Tong W; Qiu L; Qi M; Liu J; Hu K; Lin W; Huang Y; Fu J J Cell Biochem; 2018 Apr; 119(4):3641-3652. PubMed ID: 29231999 [TBL] [Abstract][Full Text] [Related]
11. Sonic hedgehog signaling inhibition provides opportunities for targeted therapy by sulforaphane in regulating pancreatic cancer stem cell self-renewal. Rodova M; Fu J; Watkins DN; Srivastava RK; Shankar S PLoS One; 2012; 7(9):e46083. PubMed ID: 23029396 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors. Benvenuto M; Masuelli L; De Smaele E; Fantini M; Mattera R; Cucchi D; Bonanno E; Di Stefano E; Frajese GV; Orlandi A; Screpanti I; Gulino A; Modesti A; Bei R Oncotarget; 2016 Feb; 7(8):9250-70. PubMed ID: 26843616 [TBL] [Abstract][Full Text] [Related]
13. Effects of baicalein on pancreatic cancer stem cells via modulation of sonic Hedgehog pathway. Song L; Chen X; Wang P; Gao S; Qu C; Liu L Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):586-596. PubMed ID: 29697746 [TBL] [Abstract][Full Text] [Related]
14. Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. Shankar S; Nall D; Tang SN; Meeker D; Passarini J; Sharma J; Srivastava RK PLoS One; 2011 Jan; 6(1):e16530. PubMed ID: 21304978 [TBL] [Abstract][Full Text] [Related]
15. Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition. Miyazaki Y; Matsubara S; Ding Q; Tsukasa K; Yoshimitsu M; Kosai K; Takao S Mol Cancer; 2016 Jun; 15(1):49. PubMed ID: 27349387 [TBL] [Abstract][Full Text] [Related]
16. GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis. Srivastava RK; Kaylani SZ; Edrees N; Li C; Talwelkar SS; Xu J; Palle K; Pressey JG; Athar M Oncotarget; 2014 Dec; 5(23):12151-65. PubMed ID: 25432075 [TBL] [Abstract][Full Text] [Related]
17. Hedgehog signaling drives cellular survival in human colon carcinoma cells. Mazumdar T; DeVecchio J; Shi T; Jones J; Agyeman A; Houghton JA Cancer Res; 2011 Feb; 71(3):1092-102. PubMed ID: 21135115 [TBL] [Abstract][Full Text] [Related]
18. α-Mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (Kras(G12D), and Kras(G12D)/tp53R270H) mice. Verma RK; Yu W; Shrivastava A; Shankar S; Srivastava RK Sci Rep; 2016 Sep; 6():32743. PubMed ID: 27624879 [TBL] [Abstract][Full Text] [Related]
19. The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer. Mazumdar T; DeVecchio J; Agyeman A; Shi T; Houghton JA Oncotarget; 2011 Aug; 2(8):638-45. PubMed ID: 21860067 [TBL] [Abstract][Full Text] [Related]